Albemarle Corporation, ICL joint venture agreement polymeric flame retardant production

Albemarle, ICL collaborate for polymeric flame retardants

6:57 AM, 30th August 2014
Albemarle Corporation, ICL joint venture agreement for polymeric flame retardant production

TEL AVIV, ISRAEL/BATON ROUGE, US: Albemarle Corporation and ICL have entered into an agreement to establish a manufacturing joint venture for the production of ICL’s FR-122P polymeric flame retardant and Albemarle’s GreenCrest polymeric flame retardant. These flame retardants are designed to replace hexabromocyclododecane (HBCD). HBCD has been the leading flame retardant used in expanded (EPS) and extruded (XPS) polystyrene foam applications, but is being phased out in the European Union (EU), Japan and other countries.

The joint venture and its partners will own and operate a 2,400 metric tonne per year Netherlands plant, which is currently operating, and a 10,000 metric tonne per year Israel plant, which is scheduled to come on line in the 4th quarter of 2014. Both plants are located at ICL sites as previously announced by ICL. The joint venture will enable additional capacity to be brought to the market to meet the growth needed for the EU and the rest of the world following the phase out of HBCD from these markets. The transaction is subject to certain closing conditions, including regulatory approvals, and is expected to close in 2015.

“The joint venture will allow Albemarle to continue providing its GreenCrest branded product to customers while joining forces with a proven manufacturing partner in ICL. The combined experience and know-how related to bromine and bromine derivatives of Albemarle and ICL will ensure a reliable, high quality alternative offering to HBCD in the EPS/XPS segment. In addition, Albemarle brings its financial backing and GreenCrest product manufacturing experience to the venture,” said Troy De Soto, Vice President, Fire Safety Solutions, Albemarle.

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Potential therapy may treat Sudan ebola virus in future

WASHINGTON DC, US: Ebola is a rare, but deadly disease that exists as five strains, none of which have approved therapies. One of the most lethal stra ...

Read more
New method to grow germanium nanowires, improves lithium ion batteries

MISSOURI, US: Researchers at Missouri University of Science and Technology have developed what they call “a simple, one-step method” to gr ...

Read more
AkzoNobel to establish new organization for performance coatings business

AMSTERDAM, THE NETHERLANDS: AkzoNobel will establish a new organization for its performance coatings business area in order to drive leading performan ...

Read more
Agrium to acquire controlling interest in Agricen

LOVELAND, US: Loveland Products, a subsidiary of Agrium and a leading global provider of high-performance crop input products and proprietary products ...

Read more
Amerigen, Ningbo Menovo to develop generic pharmaceuticals in US

LYNDHURST, US/NINGBO, CHINA: Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co Ltd have entered into a collaboration agreement ...

Read more
New method to prevent organic food fraud

WASHINGTON DC, US: A growing number of consumers are willing to pay a premium for fruits, vegetables and other foods labelled “organic,” b ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X